KCNA3 and Alzheimer disease: Recent studies have analyzed the effect of KV1.3 blockers on microglial profiles in AD models and confirm that pro-inflammatory and neurotoxic microglia functions are reduced with different KV1.3 inhibitors (Figure 2B).